Neogen Chemicals Limited announced its un-audited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. The company reported a revenue of ₹288 crore for the quarter ended September 30, 2026, and a profit after tax of ₹21.14 crore. For the half year ended September 30, 2026, revenue stood at ₹540.28 crore with a profit after tax of ₹40.58 crore. The company also approved an increase in the threshold for loans and investments up to ₹500 crore.
Neogen Chemicals Reports Q2 FY27 Financials
Neogen Chemicals Limited has released its un-audited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. The Board of Directors considered and approved these results, which showed a revenue of ₹288 crore for the quarter and a profit after tax of ₹21.14 crore. For the half year ended September 30, 2026, the company recorded a revenue of ₹540.28 crore and a profit after tax of ₹40.58 crore.
Key Financial Highlights
Standalone Results (Quarter Ended September 30, 2026)
- Revenue from operations: ₹288.00 crore
- Profit after tax: ₹21.14 crore
Standalone Results (Half Year Ended September 30, 2026)
- Revenue from operations: ₹540.28 crore
- Profit after tax: ₹40.58 crore
Consolidated Results (Quarter Ended September 30, 2026)
- Revenue from operations: ₹295.96 crore
- Profit after tax: ₹8.23 crore
Consolidated Results (Half Year Ended September 30, 2026)
- Revenue from operations: ₹546.25 crore
- Profit after tax: ₹25.34 crore
Other Key Approvals
In addition to the financial results, the Board also approved an increase in the threshold for granting loans, ICDs, corporate guarantees/securities, and making investments in securities up to ₹500 crore under Section 186 of the Companies Act, 2013. This approval is subject to member approval and requires an ordinary resolution.
The company also announced the expansion of its Organo-Lithium chemicals manufacturing facility from 300 MT/PA to 600 MT/PA, with an estimated investment of up to ₹45 crore. This expansion is expected to generate additional revenue of ₹150 crore to ₹200 crore annually.
Material related party transactions with subsidiaries, Neogen Morita New Materials Limited and Neogen Ionics Limited, were also approved, subject to shareholder approval. These transactions, spanning various services and financial arrangements, are projected to be up to ₹500 crore for corporate guarantees and other transactions.
Auditor’s Review Report
The unaudited financial results have been reviewed by M/s. Chandabhoy Jassoobhoy, Chartered Accountants. The auditors’ report confirms that, based on their review, nothing has come to their attention that causes them to believe that the accompanying statement is not free of material misstatement and that the required disclosures have been made in accordance with the Listing Regulations.
Source: BSE
